“How Value Added Medicines (VAMs) can deliver more accessible off-patent innovation in Europe” 4th Value Added Medicines Conference Medicines for Europe, Brussels
Speaking Engagement | 11.30.22
Contacts
Insights
Speaking Engagement | 09.09.26
Speaking Engagement | 05.07.26
Speaking Engagement | 04.29.26
"Styrene: The draft proposal to reclassify in Europe Webinar," Crowell & Moring Webinar.

